JORDEN DAVID EMERSON (CEO, CFO) exercised options at NUO THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/3/2026ACC: 0001437749-26-022665
DirectorOfficer· CEO, CFO
Since Aug 2018
-35.89K
Net shares
Net seller
$162.5K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
287.50K acquired · 323.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+162.50K
Price / share
$1.00
Trade value
$162.50K
% of position
7.9%
6/30/2026
2.06M→2.22M
Common Stock
Direct
Shares
−160.89K
Price / share
$1.01
Trade value
$162.50K
% of position
7.2%
6/30/2026
2.22M→2.06M
Total
Net shares
+1.61K
Net value
-$0.92
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | M · Option Exercise | +162.50K | $1.00 | $162.50K | 7.9% | 2.06M | 2.22M |
| Common Stock Direct | 6/30/2026 | F · Tax Withholding | −160.89K | $1.01 | $162.50K | 7.2% | 2.22M | 2.06M |
| Total | +1.61K | -$0.92 | ||||||
Derivative Transactions2
Option to purchase common stock
Direct
Converts to
Common Stock
125K shares
Shares
+125K
Strike price
1.01
Held after
125K
Exercisable
—
6/29/2026
Option to purchase common stock
Direct
Converts to
Common Stock
162.50K shares
Shares
−162.50K
Strike price
1
Held after
0.00
Exercisable
—
6/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase common stock Direct | Common Stock125K shares | 6/29/2026 | A · Award | +125K | 1.01 | — | 125K |
| Option to purchase common stock Direct | Common Stock162.50K shares | 6/30/2026 | M · Option Exercise | −162.50K | 1 | — | 0.00 |